Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SSAT058 switch study from Atripla to Eviplera for CNS function in adults with HIV infection
2014-002284-15Phase 4Completed
- Sponsor
- St Stephen's AIDS Trust
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of emtricitabine + rilpivirine + tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV), sponsored by St Stephen's AIDS Trust. Started Jul 2015; status: completed.
02
Drugs
emtricitabine + rilpivirine + tenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2014-002284-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002284-15.